Bharat Biotech International Ltd on Wednesday said its oral Cholera Vaccine Hillchol has successfully completed phase III ...

Hyderabad: Bharat Biotech International Ltd on Wednesday said its oral Cholera Vaccine Hillchol has successfully completed phase III clinical trials. The vaccine maker, in a press release, said it has ...

Pursuant to Regulation 30 and 33 of SEBI (LODR) regulations, 2015, as amended from time to time. We enclosed herewith Unaudited Standalone and Consolidated Financial results of the company for the ...

Going public via SPAC was a very 2021 thing to do. During the peak of the last bull market, dozens of startups took this quick route to market, merging with publicly traded shell companies, or SPACs, ...

The fate of a small, pri­vate­ly-held biotech’s new drug has been de­layed, in what ap­pears to be a sign that broad cuts to the FDA … ...

In the basement of 55 Church St. sits one of just three NeuroExplorer PET scanners in the world. Capable of producing images with significantly better resolution and sensitivity than its 20-year-old ...

Octagon Therapeutics has thrown in the towel. The Novo Nordisk-allied autoimmune disease biotech is winding down after deprioritizing its lead program and running into unresolved biology questions.

Biotech firm Jade Biosciences Inc. has completed its merger with Aerovate Therapeutics Inc. (Nasdaq:AVTE), in a move that will put the former on the Nasdaq. Jade’s Vancouver-based CEO, Tom ...

PITTSBURGH, April 28, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) announced today that on April 23, 2025, the European Commission (EC) granted marketing ...

Rather, with so much uncertainty, investors are prizing biotech companies that base their intellectual property and manufacturing in the U.S., which up until now often meant higher taxes.